Using Cannabidiol in Treatment Resistant Epilepsies: The Efficacy of CBD in Children With Dravet Syndrome

2.50
Hdl Handle:
http://hdl.handle.net/10755/623433
Category:
Full-text
Format:
Text-based Document
Type:
Poster
Level of Evidence:
N/A
Research Approach:
N/A
Title:
Using Cannabidiol in Treatment Resistant Epilepsies: The Efficacy of CBD in Children With Dravet Syndrome
Author(s):
Stockhover, Holly A.
Lead Author STTI Affiliation:
Alpha
Author Details:
Holly A. Stockhover, BSN, School of Nursing, Indiana University Purdue University - Columbus, Columbus, Indiana, USA
Abstract:

The project is an educational poster displaying data from literature highlighting the promising effects of cannabidiol (CBD) in Treatment Resistant Epilepsies such as Dravet Syndrome (DS). It sheds light on the efficacy and growing use of CBD in children with DS and other epilepsy syndromes.

Keywords:
Cannabidiol; Children; Dravet Syndrome
Repository Posting Date:
23-Oct-2017
Date of Publication:
23-Oct-2017
Other Identifiers:
CONV17PST224
Conference Date:
2017
Conference Name:
44th Biennial Convention
Conference Host:
Sigma Theta Tau International, the Honor Society of Nursing
Conference Location:
Indianapolis, Indiana, USA
Description:
44th Biennial Convention 2017 Theme: Influence Through Action: Advancing Global Health, Nursing, and Midwifery.

Full metadata record

DC FieldValue Language
dc.language.isoen_USen
dc.type.categoryFull-texten
dc.formatText-based Documenten
dc.typePosteren
dc.evidence.levelN/Aen
dc.research.approachN/Aen
dc.titleUsing Cannabidiol in Treatment Resistant Epilepsies: The Efficacy of CBD in Children With Dravet Syndromeen_US
dc.contributor.authorStockhover, Holly A.en
dc.contributor.departmentAlphaen
dc.author.detailsHolly A. Stockhover, BSN, School of Nursing, Indiana University Purdue University - Columbus, Columbus, Indiana, USAen
dc.identifier.urihttp://hdl.handle.net/10755/623433-
dc.description.abstract<p><span>The project is an educational poster displaying data from literature highlighting the promising effects of cannabidiol (CBD) in Treatment Resistant Epilepsies such as Dravet Syndrome (DS). It sheds light on the efficacy and growing use of CBD in children with DS and other epilepsy syndromes.</span></p>en
dc.subjectCannabidiolen
dc.subjectChildrenen
dc.subjectDravet Syndromeen
dc.date.available2017-10-23T17:54:43Z-
dc.date.issued2017-10-23-
dc.date.accessioned2017-10-23T17:54:43Z-
dc.conference.date2017en
dc.conference.name44th Biennial Conventionen
dc.conference.hostSigma Theta Tau International, the Honor Society of Nursingen
dc.conference.locationIndianapolis, Indiana, USAen
dc.description44th Biennial Convention 2017 Theme: Influence Through Action: Advancing Global Health, Nursing, and Midwifery.en
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.